BioStem Technologies, Inc.
Formerly Caribbean International Holdings, Inc., Caribbean Casino & Gaming Corporation
BioStem Technologies, Inc. is listed today as BioStem Technologies, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2026 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| May 2026 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
BioStem Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2026).
SEC Form D · Oct 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Oct 2026
That is all the official record says: BioStem Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of BioStem Technologies, Inc. are on record.
Investors#
No investor of BioStem Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding BioStem Technologies, Inc. shares, as of Sep 30, 2026.
- PNC Financial Services Group, Inc.$2 M2.84%
- Vanguard Capital Management LLC$1 M2.53%
- Anson Funds Management LP$1 M1.92%
- Geode Capital Management, LLC$0 M0.74%
- Vanguard Fiduciary Trust Co$0 M0.43%
- Northern Trust Corp$0 M0.17%
- Millennium Management LLC$0 M0.13%
- UBS Group AG$0 M0.10%
- Virtu Financial LLC$0 M0.10%
- StoneX Group Inc.$0 M0.10%
- Elequin Capital, LP$0 M0.06%
- Ashton Thomas Private Wealth, LLC$0 M0.05%
- Vanguard Global Advisers, LLC$0 M0.04%
- Beaird Harris Wealth Management, LLC$0 M0.01%
- Osaic Holdings, Inc.$0 M0.01%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew Van Vurst | Executive officer | Jun 2026 |
| Barry Hassett | Executive officer | Jun 2026 |
| Brandon Poe | Executive officer | Jun 2026 |
| Jason Matuszewski | Executive officer | Jun 2026 |
| Katherine Gorrell | Executive officer | Jun 2026 |
| Jodi Ungrodt | Director | Oct 2026 |
| Mark Glickman | Director | Oct 2026 |
| Rayna Lesser Hannaway | Director | Oct 2026 |
| Steven Sonenreich | Director | Oct 2026 |
| Andrew Van Vurst | Director | Jun 2026 |
| Jason Matuszewski | Director | Jun 2026 |
| Jodi J. Ungrodt | Director | Jun 2026 |
| Kenneth Warrington | Director | Jun 2026 |
| Patrick J. Daly | Director | Jun 2026 |
| Thomas J. Dugan | Director | Jun 2026 |
Went public since 2025. Its SEC number is that of a company listed on a stock exchange.